Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that causes lesions in areas where skin rubs together, such as the armpits or groin. Studies suggest that people living with HS may have a higher risk of nonmelanoma skin cancer, especially squamous cell carcinoma (SCC).
If you’re living with HS, understanding this connection can help you watch for possible skin cancer symptoms. Finding skin changes early may improve the chances of successful treatment before cancer spreads.
Hidradenitis suppurativa is associated with a higher risk of several types of cancer, including nonmelanoma skin cancer.
One study found that people with HS were 4.6 times more likely to develop nonmelanoma skin cancer. Another study found that people with HS were a little more than twice as likely to develop nonmelanoma skin cancer compared with the general population.
The second study was conducted in Asia, where skin cancer rates are generally lower than in other populations. This may partly explain the lower risk estimate.
A systematic review and meta-analysis of 11 studies that included 624,000 people with HS found that people with HS had a significantly higher overall cancer risk.
However, unlike some smaller studies, this analysis did not find an increased risk of skin cancers or melanoma. These findings suggest that shared risk factors, including smoking and metabolic conditions, may contribute more strongly to cancer risk.
More research is needed to understand how often people with HS develop skin cancer.
The exact connection between hidradenitis suppurativa and skin cancer is still unclear. Some researchers believe chronic inflammation may play a role. HS causes ongoing inflammation over time, and long-term inflammation is a known cancer risk factor.
Researchers also think that human papillomavirus (HPV) may contribute to the connection in some people.
One study looked at the link between squamous cell carcinoma and HS. Researchers found that about 30 percent of people with both HS and SCC also had HPV.
Another study suggested that HS may cause problems with lymphatic drainage. This may weaken the immune system’s ability to detect and destroy cancerous cells.
More large studies are needed to better understand how HS may raise skin cancer risk.
Researchers have identified several factors that may increase skin cancer risk in people with HS, including:
Having one of these risk factors doesn’t mean you’ll definitely develop skin cancer. Talk with your dermatologist about your personal level of risk.
One important way to lower the risk of advanced skin cancer is to report skin changes to your doctor promptly. Diagnosing skin cancer early allows treatment to begin before the cancer metastasizes (spreads to other parts of the body).
If you’re living with HS, checking your skin regularly at home can help you spot possible signs of skin cancer. Tell your doctor about any lesions that are new, changing, painful, or not healing.
Skin cancer can be harder to detect in people with HS. HS can cause discoloration, scabbing, crusting, and uneven skin texture, which may make cancer warning signs less noticeable.
That’s why regular skin exams with a dermatologist are important. Health experts often recommend annual skin checks. Try to see a dermatologist who’s familiar with HS and can tell the difference between HS lesions and skin cancer.
Skin exams at home or at the doctor’s office should include your entire body, not just areas affected by HS.
People living with HS should be on the lookout for symptoms of nonmelanoma skin cancer. The two most common types of these are basal cell carcinoma (BCC) and SCC. Each type can cause different symptoms.
Cutaneous squamous cell carcinoma is a recognized but infrequent complication of hidradenitis suppurativa.
Several treatment options for skin cancer are available. These treatments are generally the same for people with HS and those who don’t have it.
Surgery is often used to remove the cancer and a small border of nearby healthy tissue to help prevent the cancer from spreading.
Sometimes, radiation, chemotherapy, or other therapies are also needed to treat skin cancer. Skin cancer treatments may be applied directly to the skin, taken by mouth, or given through an IV infusion.
Your healthcare team can explain which treatments may be most appropriate for your type of skin cancer.
If you’re living with HS, talk with your dermatology team about managing your cancer risk. They can help you understand your risk and recommend ways to monitor your skin and catch problems early.
On MySkinCancerTeam, people share their experiences with skin cancer, get advice, and find support from others who understand.
Have you had skin cancer while living with HS? Let others know in the comments below.
Get updates directly to your inbox.